Open access
Jul 2026
Integrated transcriptomic and Mendelian randomization analysis identifies novel biomarkers for type 2 diabetes-associated cardiac dysfunction: cynaropicrin as a candidate intervention.
Cynaropicrin demonstrates candidate cardioprotective and metabolic benefits in diabetic rats; however, its direct molecular targets and mechanism of action require further validation.
Lindong Zhang, Lingling Qin, Lili Wu et al.
· Naunyn-Schmiedeberg's Archiv... · 0 citations